- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 23
Consent of Independent Auditors
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-02441, 333-07661, 333-15819, 333-22153, 333-31795, 333-48042, 333-48385, 333-57234 and 333-100123) and in the related Prospectuses and on Form S-8 (Nos. 333-41534, 333-73544, 333-47543, 333-53292, 333-75372, and 333-75374) pertaining to the ImmunoGen, Inc. Restated Stock Option Plan and the ImmunoGen, Inc. 2001 Non-Employee Director Stock Plan of our report dated July 25, 2003 (except for Note J, as to which the date is July 31, 2003), with respect to the consolidated financial statements and financial statement schedule of ImmunoGen, Inc. included in the Annual Report (Form 10-K) for the year ended June 30, 2003.
/s/ Ernst & Young LLP
Boston, Massachusetts
September 23, 2003
Consent of Independent Auditors